Project Grant R01GM155542
Award Date
9/21/24
Completion Date
8/31/29
Dollars Obligated
$314K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $1,084,158 to the Regents of the University of Michigan to advance the study of RNA-protein interactions (RPIs) and RNA-binding proteins (RBPs). The key objectives of this 5-year project are to: 1) continue developing the university's live-cell RPI assay technology (RIPCA) as a scalable platform for validating and...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $424,264 to the Regents of the University of Michigan to conduct advanced quantitative analyses of long-read RNA sequencing data at both the bulk and single-cell levels. The key products and services to be delivered include: Development of bioinformatics methods to enable discovery of differentially expressed gene...
The National Institute of General Medical Sciences (NIGMS) has awarded a 5-year, $787,500 Project Grant under CFDA 93.859 Biomedical Research and Research Training to the Regents of the University of California at Riverside. This grant will support research to investigate the roles of nuclear RNA modifications in gene regulation. The project aims to study three key nuclear RNA modifications - the 5' polyphosphate group, the m2,2,7G cap, and the m5C modification - and how they impact mRNA,...
The National Institute of General Medical Sciences (NIGMS) awarded a $905,853 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Molecular Instruments, Inc. to develop innovative signal amplification technologies for automated, ultrasensitive, and multiplex imaging of RNA and proteins in biological samples. The 2-year project aims to engineer novel chromogenic and fluorescent signal amplification cascades based on hybridization chain reaction (HCR) to enable 4-plex RNA in...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to understand the impact of controlled 3D topographical design on biological interactions. The award of $374,595 to the Regents of the University of Michigan aims to develop versatile 3D topographic nanopatterning tools that can accurately replicate dynamic 3D topographies found in natural biological systems. The...
This federal Project Grant award of $123,737.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to advance drug discovery for protein domains containing intrinsically disordered regions. The award was granted to the Regents of the University of Michigan, a prominent U.S. state government-owned educational institution, with a performance period from October 1, 2024 to April 30, 2025. The NIGMS...
This Project Grant award of $388,621 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of novel molecular designs with therapeutic potential. The key objectives are: Developing ligand-heterocycle conjugates as targeted RNA degraders with rapid kinetics and selectivity for cancer-associated G-quadruplexes. Engineering nucleic acid polymers with (thio)phosphoramidate backbones as biostable...
This Project Grant award of $372,210 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to advance RNA-centered therapeutics. The key products and services to be delivered under this 5-year award include: Creating modified antisense oligonucleotides (ASOs) and short interfering RNAs (siRNAs) incorporating fluorescent ribonucleosides to enable live-cell imaging of therapeutic oligonucleotide uptake and...
The National Institute of General Medical Sciences (NIGMS) awarded a $528,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Sloan-Kettering Institute for Cancer Research located in New York, NY. The purpose of this 4-year grant, with a period of performance from September 30, 2024 to July 31, 2028, is to develop novel approaches to map the folding and protein occupancy of entire chromosomes with single-nucleosome resolution and single-molecule precision. The...
This $700,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of next-generation RNA interference (RNAi) therapeutics and the creation of an in vivo mouse model to evaluate their efficacy and biodistribution. The key objectives of the award are to: 1) generate an effective pipeline to test an array of new RNAi-based therapeutic biologics coupled to established...